Johnson, William https://orcid.org/0000-0002-0347-4354
Norris, Tom
Pearson, Natalie
Petherick, Emily S. https://orcid.org/0000-0001-6778-8128
King, James A. https://orcid.org/0000-0002-8174-9173
Willis, Scott A. https://orcid.org/0000-0001-8624-1427
Hardy, Rebecca
Paudel, Susan
Haycraft, Emma https://orcid.org/0000-0002-7359-1759
Baker, Jennifer L. https://orcid.org/0000-0002-9649-6615
Hamer, Mark https://orcid.org/0000-0002-8726-7992
Stensel, David J. https://orcid.org/0000-0001-9119-8590
Tilling, Kate
Richardson, Tom G.
Article History
Received: 27 August 2024
Revised: 17 December 2024
Accepted: 14 January 2025
First Online: 23 January 2025
Competing interests
: All authors declare that they have no conflict of interest. TGR is a full-time employee of GlaxoSmithKline outside of this research. TN is a full-time employee of AstraZeneca outside of this research. JLB declares receiving consulting fees from Novo Nordisk A/S.